Tag: Regulatory
Tobacco epidemic grips Indian youth: KPMG report
KPMG Report Exposes Consumption of Tobacco among 49% of Young Adults, Calls for Collaborative Tobacco Control Measures
MedTech Expo on 17-19th August in Gujarat to showcase 70+ innovations...
400+ exhibitors including MSMEs, domestic and international manufacturers, start-ups, regulatory bodies, state governments and central ministries and departments to participate
Agri Ministry launches NANDI portal for regulatory approval to veterinary products
The initiative is a significant step towards advancing Digital India and promoting the well-being of livestock and the livestock industry
In a first, govt notifies regulatory standards for basmati rice
The regulatory standards also specify various identity and quality parameters for basmati rice such as average size of grains and their elongation ratio after cooking
Pricing pressures & regulatory scrutiny persist in US generics pharma industry:...
Some major Indian pharmaceutical companies reported sizeable impairment losses and also announced discontinuation of some products or segments due to lower earnings potential
Sanofi & GSK to seek USFDA & EMA approval for Covid-19...
When used as a two-dose primary series, the Sanofi-GSK vaccine delivered robust levels of neutralizing antibodies, with GMTs reaching 3711 units
Dedicated national R&D policy to bolster Indian pharma sector
Experts discuss regulatory reforms, ease of doing business during health and wellness week at India Pavilion
Mankind Pharma seeks CDSCO’s nod to conduct phase-1 clinical trials of...
A patented first in class novel anti-diabetic molecule, MKP10241 is a potent and orally administered small molecule, GPR119 agonist.........................
Govt fast-tracks regulatory approvals to fight COVID -19
In order to accelerate research and development pertaining to COVID-19, the Review Committee on Genetic Manipulation (RCGM) functioning in DBT has processed/considered more than 100 applications till date, on a fast-track mode....................
Cipla gets regulatory nod to launch Ciplenza for mild & moderate...
Cipla Limited has announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.................